Philippe Soubrie
11Patents
5h-index
18Co-inventors
59Inventor score
Filing activity: Nov 17, 1989 → Apr 8, 2003
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6344474B1 | Use of central cannabinoid receptor antagonists for regulating appetence | Human Necessities | 82 | Expired |
| US5082858A | Novel chroman derivatives active on the central nervous system, their method of preparation and pharmaceutical compositions in which they are present | Chemistry; Metallurgy | 27 | Expired |
| US5026716A | Method of treatment of anxiety and anxio-depressive disorders | Human Necessities | 12 | Expired |
| US5151442A | Chroman derivative active on the central nervous system, their method of preparation and pharmaceutical compositions in which they are present | Chemistry; Metallurgy | 9 | Expired |
| US6420388B1 | Osanetant in the treatment of depression and depressive disorders | Human Necessities | 5 | Expired |
| US5604245A | Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment of conditions deriving from disorders of the serotoninergic systems mediated by 5-HT.sub.3 receptors | Human Necessities | 4 | Expired |
| US5043352A | Chroman derivatives for the treatment of depressive states | Human Necessities | 2 | Expired |
| US5852044A | Use of NK.sub.1 receptor antagonists for preparing cardio-regulatory drugs | Human Necessities | 1 | Expired |
| US6573281B1 | Use of saredutant for the treatment of adaptation, bipolar, and dysthymic disorders | Human Necessities | 1 | Expired |
| US7390823B2 | Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders | Human Necessities | 0 | Expired |
| US5286734A | Arylpiperidine derivative, process for the preparation thereof and pharmaceutical compositions containing it | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.